Farim Duo Tablets 5/500 milligrams
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Ahn-Guk Pharmaceutical Co., Ltd.
MFDS item code 202201358 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct treatment to diet and exercise to improve blood sugar control in adult patients with type 2 diabetes. It is particularly suitable for patients whose blood sugar is not adequately controlled, and caution is required when used in conjunction with cardiovascular diseases. Clinical trial information should be referenced to ensure safe administration. This medication helps in blood sugar control and prevention of cardiovascular events.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each active ingredient: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medicines, such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin that they were taking previously. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose of this medicine is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication helps reduce blood sugar. However, it can cause rare but serious side effects such as severe lactic acidosis, so caution is necessary. When taken with other diabetes medications, hypoglycemia may occur, so care must be taken. Patients with moderate to severe renal impairment, acute kidney problems, severe infections, or heart conditions should not use this medication. This medication should be temporarily discontinued before and after surgery or radiological examinations, and may only be resumed after kidney function is confirmed to be normal. Patients with poor liver function or excessive alcohol intake should also avoid this medication. Pregnant or breastfeeding women should not take this medication. The dosage of this medication needs to be adjusted based on kidney function, and kidney function tests should be performed regularly. Additionally, this medication may cause side effects such as hypoglycemia, urinary tract infections, genital infections, and increased urination, so immediate consultation with medical personnel should occur if symptoms appear. If there is a risk of fluid loss, attention should be paid to signs of dehydration, and the medication may be temporarily discontinued if necessary. Vitamin B12 levels may decrease, so regular testing is recommended. Alcohol consumption should be avoided while taking this medication, and caution is advised in cases of sudden weight changes, irregular meals, or vigorous exercise. Moreover, this medication may interact with other drugs, so it is important to inform your doctor or pharmacist if you are taking any other medications. Elderly patients are at greater risk of kidney function decline and should be extra cautious, and it is not recommended for children under 18. In case of overdose, you should visit a hospital immediately for appropriate treatment, as this medication can be removed through dialysis. This medication should be stored out of reach of children and in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or humidity. Additionally, it is best kept at room temperature between 1°C and 30°C. This will help maintain the effectiveness of the medication for a longer period.
Orange-yellow, convex oval film-coated tablet on both sides
10 tablets/box [10 tablets/PTP X 1], 60 tablets/box [10 tablets/PTP X 6], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Ahn-Guk Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.